Two incretin-based drugs linked to increased bile duct disease but not pancreatitis

At least two incretin-based drugs – glucagon-like peptide 1 agonists and dipeptidyl peptidase 4 inhibitors – do not appear to increase the risk of acute pancreatitis in individuals with diabetes but...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news